In January 2021, Pfizer, the manufacturer of the rheumatoid arthritis drug Xeljanz®, announced the results of the safety clinical trial mandated by the U.S. Food
Popular rheumatoid arthritis, psoriatic arthritis, and ulcerative medication Xeljanz has been potentially linked to MACE injuries, strokes, and blood clots through a clinical study. These
Popular rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis medication Xeljanz has been potentially linked to causing strokes and blood clots. Review our Xeljanz Safety Evaluation
Preliminary results from an FDA-mandated study conducted by Xeljanz and Xeljanz XR’s manufacturer, Pfizer, found that patients taking the popular rheumatoid arthritis medication are at
Goldenberglaw uses cookies and similar technologies as strictly necessary to make our site work. We and our partners would also like to set additional cookies to analyze your use of our site, to personalize and enhance your visit to our site and to show you more relevant content and advertising. For more information, please read our Privacy Statement.
